Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MediciNovaTSE:4875 +0.89%31 Market Cap is 円11,289.4 Mil as of Aug. 31, 2026. GuruFocus rates TSE:4875 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 1,421 Biotechnology companies, MediciNova ranks worse than 58.34% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). MediciNova's share price for the quarter that ended in Jun. 2026 was 円209. MediciNova's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 49.2 Mil. Therefore, MediciNova's market cap for the quarter that ended in Jun. 2026 was 円10,287.2 Mil.
MediciNova's quarterly market cap
increased
from Dec. 2025 (円10,631.7 Mil) to Mar. 2026 (円10,976.3 Mil) but then
declined
from Mar. 2026 (円10,976.3 Mil) to Jun. 2026 (円10,287.2 Mil).
MediciNova's annual market cap
increased
from Dec. 2023 (円10,299.7 Mil) to Dec. 2024 (円16,381.4 Mil) but then
declined
from Dec. 2024 (円16,381.4 Mil) to Dec. 2025 (円10,631.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MediciNova's Enterprise Value for Today is 円7,259.8 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
MediciNova Market Cap Related Terms
MediciNova Market Cap Historical Data
* Premium members only.
The historical data trend for MediciNova's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4875 vs SPRO, XBIT, CRDF: Market Cap Comparison
For the Biotechnology subindustry, MediciNova's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MediciNova Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MediciNova's Market Cap distribution charts can be found below:
* The bar in red indicates where MediciNova's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
MediciNova's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MediciNova (TSE:4875) has a Market Cap of 円11,289.4 Mil as of Aug. 31, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MediciNova and its competitors. According to the industry distribution chart, MediciNova ranks #829 out of 1421 companies in the Biotechnology industry, placing it in the top 58.3%.
Is MediciNova's Market Cap too high?
MediciNova's current Market Cap is 円11,289.4 Mil. Based on the distribution chart, MediciNova ranks #829 out of 1421 companies in the Biotechnology industry, which is below the industry midpoint. Overall, MediciNova has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does MediciNova's Market Cap compare to SPRO and XBIT?
According to the Biotechnology industry distribution chart, MediciNova ranks #829 out of 1421 companies for Market Cap. This places MediciNova in the lower half of its industry. The industry median Market Cap is 122.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 122.34, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MediciNova and its competitors. For the Biotechnology industry, the median Market Cap is 122.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MediciNova's current Market Cap is 円11,289.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediciNova stock overvalued right now?
MediciNova (TSE:4875) has a current Market Cap of 円11,289.4 Mil. The current Market Cap is 円11,289.4 Mil. MediciNova's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For MediciNova (TSE:4875), the current Market Cap is 円11,289.4 Mil as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
31GF Score
Get the complete analysis for TSE:4875
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4875 has been successfully added to your 
